Study of Methylnaltrexone (MNTX) for the Relief of Constipation

Completed · Phase 3 · Has a placebo group

Conditions studied: Advance Illness Patients With OIC

In brief

To determine the efficacy of subcutaneous MNTX to relieve opioid-induced constipation in patients with advanced medical illness.

Key facts

Study ID

NCT00402038

Run by

Bausch Health Americas, Inc.

People needed

134

Starts

2004-02-01

Expected to finish

2005-10-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older
• Negative pregnancy test (serum or urine) at screening for all women of childbearing potential
• Advanced Medical Illness (i.e., terminal illness, such as incurable cancer or end of stage AIDS) with life expectancy of ≥ 1 month
• patient must sign ICF

You may not qualify if…

• Women who are pregnant and/or nursing
• Previous treatment with MNTX
• Participation in any other studies involving investigational products within 30 days prior to screening

Where it is running

• Progenics Pharmaceuticals, Inc. — Tarrytown, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.